Pharma Two B
Mr. Tonelli joined Galmed in March, 2015, bringing 24 years of progressive experience in clinical development, operations and regulatory affairs. From 2005-2014, he planned and managed diabetes trials at MannKind Corporation, culminating in FDA approval of Afrezza® Inhalable Insulin. Prior to MannKind he held leadership positions in clinical development and project management at Innapharma. He began his career in regulatory affairs in the Medical Research Division of American Cyanamid (Lederle Labs). Mr. Tonelli holds a Bachelor of Science degree from Rutgers University.